Histiocytoses and Hematology
The major aim of our studies is to improve survival and reduce long-term sequele in children affected by cancer and blood disorders, with focus on hematological disorders and histiocytoses (hemophagocytic lymphohistiocytosis, HLH, and Langerhans cell histiocytosis, LCH). We aim to develop better treatment regimens, and better diagnostic and monitoring tools.
Research group leader:
With the ultimate target to improve treatment and outcome, we also investigate underlying genetics, immunology and biology of the disorders. In addition, we also study psychosocial factors affecting children with cancer and their parents. Our studies range from molecular biology, through cellular studies to clinical studies and psychosocial investigations. They comprise the following main areas which are presented in detail.
- Hemophagocytic Lymphohistiocytosis (HLH) Clinical Studies
- Hemophagocytic Lymphohistiocytosis (HLH) Biological Studies
- Langerhans Cell Histiocytosis (LCH)
- Hematological disorders [Kostmann's disease (SCN), and ITP]
Members of the research group
Göran Carlsson, MD PhD Senior consultant
Désirée Gavhed, PhD Project coordinator
AnnaCarin Horne, MD PhD Fellow in paediatrics
Elisabet Berglöf, PhD Research assistant
Miriam Entesarian, PhD Postdoc
Magdalini Lourda, Postdoc